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ABSTRACT 
The oral route of administration remains the most convenient route of administration but the major disadvantage is dysphagia (difficulty in 
swallowing) to overcome these problems novel drug delivery systems have developed mouth dissolving tablets with improved patient 
compliance. Mouth dissolving tablets are solid dosage forms which dissolve rapidly when kept in mouth. The first choice of dr ugs for pediatric, 
geriatric, mentally disable patients and also for patients who are traveling can administer the tablet any time without the need for water. 
Conventional technologies and patented technologies are the two different technologies used in the manufacturing of MDTs. This review 
describes the various aspects of MDT formulation, super disintegrants, and technologies used for developing MDT, along with evaluation 
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INTRODUCTION [1,2,3]: 
The oral route of administration is the better-adapted route 
of administration of different therapeutic agents. It is 
generally preferred route due to its advantages such as 
convenience in case of self-administration, compactness and 
easy manufacturing. Infact of having so many advantages, 
the most common drawback of in oral dosage forms like 
tablets and capsules is difficulty in swallowing, particularly 
in the case of pediatric and geriatric patients, and mentally 
disabled patients. To overcome these problems, 
Pharmaceutical scientists have developed mouth 
dissolving/disintegrating tablets (MDTs). These Mouth 
Dissolving Tablets take less than three minutes to dissolve in 
the oral cavity. Mouth dissolving tablets have good taste and 
flavour and mask the bitter taste of the drugs. MDTs are 
most useful for the bed-ridden and patients who have the 
swallowing problems. Mouth dissolving tablets are also 
known as oral dispersible tablets, fast disintegrating tablets, 
orally disintegrating tablets, quick disintegrating tablets, 
fast-dissolving tablets, rapid dissolving tablets. Mouth 
dissolving tablets are formulated by two different methods 
one be patented technology and another one is non patented 
technology. The advantages of MDTs are a considerable 
dosage form, onset of action, self-administration, no risk, no 
pain increased bioavailability of the drug. 
 
Requirement of Mouth Dissolving Tablets: 
Ideal Properties of Mouth Dissolving Tablets [5]: 
1. No need for water while swallowing the tablet. 
2. It should have a pleasant mouthfeel. 
3. It should mask the bitter taste. 
4. It should be harder and less friable. 
5. No residue should be left in the mouth after 
administration. 
6. Low-cost therapy. 
Advantages  of Mouth  Dissolving Tablets [6,7]: 
1. Mouth dissolving tablets are more convenient to pediatric, 
geriatric, mentally retarded and psychiatric patients. 
 2. Bioavailability of the drug increased due to its absorption 
of from mouth, pharynx, and oesophagus as saliva passes 
down to the stomach and also avoids hepatic metabolism. 
 3. It is suitable for patients who are traveling where there is 
no access to water. 
 4. It masks the bitter taste and gives a pleasant mouthfeel. 
 5. The fast disintegration of tablets and also shows the rapid 
onset of action. 
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 6. Mouth dissolving tablets offer all the advantages of solid 
dosage forms and it is convenient to administration 
compared to liquids dosage form due to its accurate dosage 
form. 
Salient Features of Mouth Dissolving Tablets : 
1. Easy to administration for the patients who refuse to 
swallow a tablet, such as pediatric and geriatric patients and, 
psychiatric patients. 
2. Accurate dose is consumed . 
3. No need to drink water while swallowing the dosage form, 
it is highly convenient for the patients who are traveling and 
do not have water.  
4. It masks the bitter taste of the drug so it is convenient for 
pediatric to swallow the tablet. 
5. The drug is dissolved within 15 seconds and rapid, onset 
of action. 
6. Bioavailability of drugs is increased. 
Limitations of Mouth Dissolving Tablets: 
1. Antibiotics like ciprofloxacin have large doses are difficult 
to formulate in mouth dissolving tablets. 
2. Patients who take anticholinergic medication and who 
suffer from dryness of the mouth may not be allowed to take 
MDTs because it decreases saliva production while taking 
this tablet formulation. 
Technologies used for manufacturing of Mouth 
Dissolving Tablets: 
Depending upon its  ideal properties of mouth dissolving 
tablets two different manufacturing techniques are 
employed . 
1. Convectional technologies. 
2. Patented technologies. 
1.    Conventional Technologies: 
Lyophilization or Freeze-drying [8]: 
In this process water is refined from the product after 
freezing, this process is called freeze-drying. It shows rapid 
dissolution than compared to other solid dosage forms. The 
lyophilized drugs along with excipients impart glossy 
crystalline forms resulting in high porosity. The major 
drawback of this technique is that it is expensive and time 
taking the MDTs formed by this process have low 
mechanical strength, it shows low stability during high 
temperatures. 
Molding [9]: 
By using water-soluble ingredients molded tablets are 
prepared which disintegrate completely and fastly. Firstly 
the blender is moistened with hydroalcoholic solvent and 
molded into tablets under low pressure and by using the air-
drying method the solvent is removed. compared to 
compressed tablets molded tablets do not possess great 
mechanical strength. the porous structures increase the 
dissolution. breakage of the molded tablets often seen 
during tablet handling. If hardness agents are added to the 
process the rate of tablet solubility decreases. 
Spray drying [10,11]: 
 This process produces highly porosity drugs and fine 
powders. the solvent is evaporated in the manufacturing. 
The  hydrolyzed and non- hydrolyzed gelatin was used as a 
supporting matrix for the production of mouth dissolving 
tablets. Mannitol is used as a bulking agent and super 
disintegrants such as sodium starch glycolate. By adding 
acidic substances like citric acid the disintegration and 
dissolution increase. This disintegration time < 20 sec . 
Mass extrusion [12]: 
 This process involves demulcent of the active mixture using 
the solvent like water-soluble polyethylene glycol and 
methanol by which subsequent expulsion of softened mass 
through the syringe to get a cylinder of the product and then 
cut into pieces using heated blade to form a tablet. These 
processes also used to coat the bitter taste of the drug. 
Phase transition process [13]: 
Kuno et al proposed this method to prepare mouth 
dissolving tablets. In this process, MDT is formed by 
compressing ingredients along with erythritol and xylitol 
and then heated to 93 °C for 15 min. Before heating, the 
tablets don't have sufficient hardness due to its slow 
compatibility. But after heating tablet hardness is increased 
due to an increase in inter particular bond.    
 Sublimation [14]: 
 The compressed tablets show slow dissolution due to its 
low porosity even though they contain high water-soluble 
ingredients. To overcome these problems inert volatile 
substances like camphor, ammonium bicarbonate, 
ammonium carbonate, benzoic acid, camphor, urea, and 
urethane are added along with other ingredients and mixed 
together and compressed and subjected to sublimation to 
improve its porosity. The tablets obtained have high 
porosity and exhibit good mechanical strength so it gets 
fastly dissolved in the saliva within 15 seconds.  
Direct compression methods [15,16]: 
 It is the easiest technique used for manufacturing of mouth 
dissolving tablets . In this method traditional equipment and 
generally available excipients are used and low 
manufacturing cost. High doses can receive end weight of 
the tablet which can overtake the other production methods. 
It is important to choose a correct concentration of 
disintegrant to get fast disintegration. Superdisintegrants 
provides quick disintegration as they are more effective at 
lower concentrations with high disintegrating efficiency and 
mechanical strength. according to the critical concentration 
of disintegrant the optimum concentration of super 
disintegrate is selected, if the concentration of the tablet 
disintegration is below then critical concentration then 
disintegration time is inversely proportional to the 
concentration of super disintegrant or if the concentration of 
the tablet disintegration is above the critical disintegration 
than the disintegration time remains the same or even 
increases. 
2.   Patented Technologies:   
Zydus technology  [17,18]:  
R.P. Scherer, Inc patented this technology. it is the first 
mouth dissolving/disintegrating tablet in the market. It is a 
unique type of freeze-dried process in which the drug is 
physically trapped into a matrix which is composed of 
saccharides and polymers . It does not require water while 
taking the tablet due to its unique freeze-dried structure it 
disintegrates instantaneously in the mouth.  Partially 
hydrolyzed gelatin, hydrolyzed dextran, dextrin, alginates, 
polyvinyl alcohol, polyvinyl pyrrolidine, acacia are the 
generally used polymers which impart strength during 
handling and also gives crystallinity, elegance, and hardness 
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to the tablets. .The product dispensed in a special blister 
pack as the tablets are lightweight and fragile. 
Nanocrystal technology [19]:  
Elan, King of Prussia patented this technology. In this 
technology, colloidal dispersions of drug substance and 
water-soluble ingredients are freeze-dried and filled into 
blister pockets. This process is commonly useful for small 
quantities of a drug because granulation, blending, and 
tableting which are highly potent methods are not used in 
this tablet manufacturing. 
Flashtab technology [20]:  
Ethypharm France patented this technology. In this 
formulation the wet and dry granulation methods are used 
for granulation of excipients the two types of excipients are 
used in this techniques i.e disintegrating agents and selling 
agents The commonly used disintegrating agents are 
reticulated polyvinylpyrrolidone or carboxymethylcellulose 
and the commonly used swelling agents are 
carboxymethylcellulose, starch, modified starch, 
microcrystalline cellulose The disintegrating time of this 
tablets is within 1 min 
Orasolv technology [21,22]: 
CIMA Labs patented this technology to produce the MDTs 
The effervescent disintegrating agents compressed with low 
pressure. 20-25% of the tablet concentration contains 
effervescent agent soft and fragile tablets are produced due 
to its low compression force. These tablets are developed in 
a controlled environment at a very low relative humidity. 
moisture impermeable blisters are used for packaging 
Durasolv technology [23]:  
  CIMA Labs patented this technology. To prepare products 
with a low amount of active drug this is the best suitable 
technology. Drug, nondirect compression fillers, and 
lubricants are used in the manufacturing of these tablets.  
dextrose, mannitol, sorbitol, lactose, and sucrose are the  
nondirect compressible fillers used for fast dissolution and 
to avoid grainy structure which is commonly present 
indirectly compressible sugar. Bottles and blisters are used 
in the packing of this dosage form. 
Wow tab technology [24,25] :  
This technology is patented by Yamanouchi. The WOW in the 
WOWTAB signifies the tablet is to be given without water. 
sugar and sugar like excipients promote this technology. 
Low and high – moldability saccharides are prepared by 
granulation and tableting methods. lactose, mannitol, 
glucose, sucrose are low moldability saccharides whereas 
maltose, maltitol, sorbitol, and oligosaccharides are high 
moldability tablets. These two moldability saccharides are 
combined to obtain a  tablet formulation with adequate 
hardness and fast dissolution rate. The tablets produced by 
this unit have adequate hardness and fast disintegration 
time. 
 Dispersible tablet technology [26]: 
 This technology is patented by Lek, Yugoslavia. In this 
technology, 8-10% of organic acids and disintegrating agents 
are added to improve the dissolution rate of MDTs. 
Disintegrating agent promotes fast swelling and increases 
the wetting capacity of the tablets which results in quick 
disintegration. Starch, modified starches, microcrystalline 
cellulose are some of the disintegrating agents. Mixing of 
disintegrants improves the disintegration time of tablets 
which is commonly less than 1 min. 
Pharmaburst technology [4]:  
This technology is patented by SPI pharma. Pharma burst 
technology utilizes the shelf co-processed excipients to 
develop MDTs. It depends on the type of active ingredients 
and the tablets dissolve within 30- 40 seconds.  In this 
process, the drug, flavouring agents, and lubricant are 
blended and are compressed into a standard tablet by the 
press with stock tooling. This process is carried under 
normal temperature and moisture conditions. Blister packs 
or bottles are used in the packing of these units.  
Frosta technology [4]:  
This technology patented by Akina. It applies the concept of 
compressing plastic granules at a low pressure to form 
strong tablets with high porosity. These granules contain 
three classes of components: 
1. A Porous and plastic material, 
2. A Water penetration enhancer, and 
3. A Binder 
The process involves commonly blending of the porous 
plastic material with a water penetration enhancer and it is 
followed by granulating with a binder. The tablets obtained 
by this unit have admirable hardness and quick 
disintegration time ranging from 15 to 30 s depending on 
the size of a tablet. 
 Oraquick technology [27]:  
The Oraquick disintegrating tablets composition applies a 
patented taste-masking technology. These tablets are 
manufactured by low-heat technique so it is suitable for 
heat-sensitive drugs. This technology is patented by K.V.S. 
Pharmaceuticals and These tablets dissolve within a few 
seconds and give superior mouthfeel. 
Evaluation of Mouth dissolving Tablet [28,29]:  
Evaluation of mouth dissolving tablets include the following 
evaluation tests 
  
· General Appearance:  
General appearance of tablets includes visual testing such as 
size, shape, colour, presence or absence of an odour, taste, 
surface texture, physical flaws, and consistency in 
identifying marking. 
·  Size and Shape: 
 The size and shape of the tablet can be described and 
monitored.  
·   Tablet thickness:  
Tablet thickness is an important characteristic in the 
evaluation of tablets. Micrometres are used for recording 
tablet thickness. 
·  Uniformity of weight: 
  In this method, twenty tablets were taken and their weight 
was determined individually. The maximum weight of one 
tablet was determined from the collective weight. The 
weight variation test would be the most accepted method of 
determining the drug content. 
·   Tablet hardness:  
The limit of hardness for the MDTs is normally kept in a 
lower range to facilitate the fast disintegration of the tablet 
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in the mouth. The hardness of the tablet may be measured 
using a conventional hardness test. 
 ·   Friability:  
 It is the mechanical strength of tablets. Roche friabilator is 
the apparatus used to determine the friability of tablets. A 
pre-weighed tablet was placed in the friabilator. Friabilator 
consists of a plastic-chamber that revolves at 25 rpm, 
dropping those tablets in each revolution.  
For 4minutes the tablets are rotated in fibillator at the end of 
the test the tablets were dusted and reweighted and the loss 
of the tablets is measured 
·  In Vivo Disintegration test : 
In this test 6 tablets are placed in distilled water which is 
used as a disintegrating medium and time taken for 
complete disintegration of tablets without any palatable 
mass remaining in the apparatus is measured.  
·   Wetting time:  
To measure the tablet wetting time ,a a piece of tissue paper 
folded twice and placed in a petri dish containing 6 ml of 
Sorenson’s buffer pH 6.8 and the tablet is placed on the 
paper, and the time taken for complete wetting is recorded 
and measured. Three trials for each batch are recorded and 
the standard diversion is also determined. 
·     In vitro dispersion time:  
 By placing a tablet in a beaker containing 50 ml of 
Sorenson’s buffer pH 6.8 the dispersion time is measured 
and three trails for each batch are recorded. 
Stability testing of drug:  
As recommended by ICH guidelines for accelerated studies 
the mouth dissolving tablets are packed and stored under 
favourable conditions 
 40 ± 1°C 
  50 ± 1°c 
  37 ±1oC 
  RH 75% ± 5% 
The tablets which remain reserved for 15 days is tested for 
its physical appearances such as visual defects, hardness, 
friability, disintegration, dissolution, and its drug content. 
The data is recorded and adapted to determine the kinetics 
of degradation by first-order reactions. Arrhenius equation 
is plotted to determine the shelf life at 25 0C for accelerated 
stability. 
Packaging of MDTs:  
The most important aspect of the manufacturing of MDTs is 
packing. The products which are obtained by different 
technologies differ in few specifications especially in 
mechanical strength to an extreme degree. Zydis, Lyon, 
Quicksolv, and Nanocrystal which are collected by the 
lyophilization process are porous in nature and have low 
physical resistance, and sensitive to moisture. Considering 
the above reasons the compounds require special packing. 
Peelable backing foils are used for packing zyids units. 
Dome-shaped blisters are special packaging units used in 
paksol and Orasolv which avoid the movement of tablets and 
prevent breaking of tablets during storage and transport. 
The products obtained from Durasolv i.e. WOW Tab, 
Pharmaburst OraQuick, Ziplets are generally packed in push-
through blisters or in bottles as they have sufficient 
mechanical strength to withstand handling and transport. 
Patient counselling in effective use of MDTs: 
As pharmacists have the opportunity to educate the patients 
for effective treatment as they know recent technologies 
 Confusion and misunderstanding about MDTs can be 
cleared by counselling the patients and the information 
provided to the patient include: 
 Storage of some MDTs should be handled carefully 
considering they do not have tolerable mechanical 
strength.  
 The patients who take anticholinergic drugs and 
suffering from dryness of mouth are not advisable to 
take MDTs. Despite the fact that no water is needed to 
allow the drug to diffuse fastly and accurately. However 
the low amount of saliva may decrease the rate of 
disintegration and can diminish the bioavailability of the 
product. 
 The patients should definitely know the difference 
between effervescent and MDTs because Some of the 
technologies use effervescence. 
 The patient needs to be counselled about differences 
between chewable and MDTs tablets. These MDTs can be 
used easily taken geriatric patients and pediatric. 
By the pharmacist's advice, and assistance about MDTs, 
all patients have better knowledge about MDTs so they 
can effectively be treated with greater convenience. 
CONCLUSION: 
Mouth dissolving tablets are novel approach under a solid 
oral drug delivery system. Mouth dissolving tablets are a 
convenience to all age group patients ( includes  pediatrics, 
geriatrics ) psychotic patients. They are the first patient’s 
choice as waters are not required for administrating so it can 
be administrated while traveling. Mouth dissolving tablets 
are cheaper than other conventional tablets and they are 
enhancing the drug release for poorly soluble drugs. Mouth 
dissolving systems are future prospective as research are 
going on to develop mouth dissolving tablets for available 
drugs as they provide fast onset of action which is the first 
doctors requirement for treatment of diseases. 
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